Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms

(2021) Sun Hee Rosenthal et al.   PLoS One

Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?

(2021) Eri Kawata et al.   International Journal of Laboratory Hematology

Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis

(2020) Matheus F Bezerra et al.   BLOOD

ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patients

(2020) Björn Andréasson et al.   BRITISH JOURNAL OF HAEMATOLOGY

Novel therapies in myelodysplastic syndromes

(2020) David M. Swoboda et al.   CURRENT OPINION IN HEMATOLOGY

Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome

(2020) Eri Kawata et al.   BRITISH JOURNAL OF HAEMATOLOGY

Treating acute myeloid leukemia in the modern era: A primer

(2020) William G. Blum et al.   CANCER

Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients

(2020) Chris Lauber et al.   Scientific Reports

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data

(2020) Giuseppe G Loscocco et al.   OncoTargets and Therapy

Genetics of MDS

(2019) Seishi Ogawa   BLOOD

The Role of New Technologies in Myeloproliferative Neoplasms

(2019) Giuseppe A. Palumbo et al.   Frontiers in Oncology

Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies

(2019) Michael A. Levy et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia

(2019) Laura Palomo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation

(2019) Melissa H. Cessna et al.   Cancer Genetics

Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia

(2019) Fei Yang et al.   Molecular Diagnosis & Therapy

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

(2018) Hsin-An Hou et al.   Blood Cancer Journal

Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms

(2018) Rebecca F. McClure et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use

(2018) Ulrike Bacher et al.   Blood Cancer Journal

Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome

(2017) James A. Kennedy et al.   JOURNAL OF CLINICAL ONCOLOGY

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

(2017) Marilyn M. Li et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

(2016) Hartmut Döhner et al.   BLOOD

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2016) Peter L. Greenberg et al.   Journal of the National Comprehensive Cancer Network

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

(2016) A Nazha et al.   LEUKEMIA

Genomic Classification and Prognosis in Acute Myeloid Leukemia

(2016) Elli Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

(2012) Jay P. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia

(2012) Alison Walker et al.   Expert Review of Hematology

Prognostically Important Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia

(2011) Tara L. Lin et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES